Live Breaking News & Updates on Roberto Pellicciari
Stay updated with breaking news from Roberto pellicciari. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Brunello Cucinelli and his family are supporting the research to develop innovative drugs for the treatment of metabolic and oncological diseases. ....
Intercept Pharmaceuticals’ acquisition by Alfasigma comes three months after the FDA again rejected the biotech’s drug as a treatment for the fatty liver disease NASH. But Intercept still has rare liver disease assets, and Italy-based Alfasigma says acquiring the company will help it expand in gastroenterology and hepatology. ....